Delpor: Implantable antipsychotics

How Delpor hopes Prozor implant for antipsychotics will lower drug spikes

While extended-release antipsychotics have been a commercial success, they still have a limited therapeutic duration and poor pharmacokinetics, resulting in poor compliance. Delpor Inc. is aiming to improve all three of these characteristics with its implantable Prozor drug delivery device.

Prozor is a tubular device 40 mm long and 4 mm in diameter that is subcutaneously implanted in the arm to provide continuous drug delivery via passive diffusion.

To deliver drugs with poor water solubility, such

Read the full 749 word article

How to gain access

Continue reading with a
two-week free trial.